+ All Categories
Home > Documents > CCRNPart1

CCRNPart1

Date post: 03-Jun-2018
Category:
Upload: paolo-vega
View: 220 times
Download: 0 times
Share this document with a friend
160
“Never let what you cannot do interfere with what you can do”  - John Wooden - CCRN REVIEW P ART 1 Sherry L. Knowles, RN, CCRN, CRNI
Transcript

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 1/160

“Never let what you cannot do

interfere with what you can do”  

- John Wooden - 

CCRN REVIEW PART 1

Sherry L. Knowles, RN, CCRN, CRNI

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 2/160

TOPICS Acute Coronary Syndromes

Acute Myocardial Infarction

Heart Blocks

Heart Failure

Cardiac Alterations

Aortic Aneurysms

Cardiomyopathy Shock States

Peripheral Vascular Disease

Hemodynamics

ARDS

Chronic Lung Disease

Drowning

Pneumonia

Pneumothorax

Pulmonary Embolism

Respiratory Failure Gastrointestinal Alterations

GI Bleeding

Pancreatitis

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 3/160

OBJECTIVES1. Understand the different types of acute coronary syndromes.

2. Identify basic coronary circulation and how it relates to different types ofmyocardial infarctions.

3. Anticipate potential complications associated with an AMI.4. Identify the standard treatment of an AMI.

5. Distinguish between various AV blocks.

6. Recognize the signs & symptoms of heart failure.

7. Identify the treatment of heart failure.

8. Recognize the general definition and classifications of aortic aneurysms.

9. Understand the different types of aortic dissections.

10. Recognize the signs & symptoms of cardiomyopathy.

11. Differentiate between the different types of cardiomyopathy.

12. Identify the treatment for the different types of cardiomyopathy.

13. Understand the different stages of shock.

14. Differentiate between different types of shock.

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 4/160

OBJECTIVES15. Distinguish between arterial and venous peripheral vascular disease.

16. Identify the various treatments for peripheral vascular disease.

17. Define respiratory failure.

18. Identify the various treatments for acute respiratory failure.

19. Recognize the signs & symptoms and causes of various respiratoryalterations.

20. Identify the standard treatment for various respiratory alterations.

21. Identify the components of cardiac output and stroke volume.

22. Recognize the pulmonary artery catheter waveforms.

23. Recognize the basic treatments used for commonly seen hemodynamicprofiles.

24. Explain the common causes of gastrointestinal bleeding.

25. Describe the most commonly seen treatments for GI bleeding.

26. Describe the signs & symptoms of acute pancreatitis and availabletreatments.

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 5/160

 Acute Coronary

Syndromes

 Acute MI

 Aortic Aneurysms

Cardiac Alterations

Cardiovascular Conditions

Cardiomyopathy

Heart Blocks

Heart Failure

Shock States

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 6/160

DEFINITIONS

 – Term used to cover a group of symptomscompatible with acute myocardial ischemia

 –  Acute myocardial ischemia is insufficient blood

supply to the heart muscle usually resulting from

coronary artery disease

 Acute Coronary Syndrome

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 7/160

DEFINITION

 – Infarction occurs due to mechanical obstructionof a coronary artery (or branch) caused by a

thrombus, plaque rupture, coronary spasm

and/or dissection.

 – STEMI vs. NSTEMI (non-STEMI)

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 8/160

SIGNS & SYMPTOMS

 – Complains Vary

May include crushing chest pain (which may or may

not radiate), back, neck, jaw, teeth and/or epigastric

pain, SOB, nausea/vomiting and dizziness

 – ST elevations on ECG – Elevated cardiac enzymes

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 9/160

SIGNS & SYMPTOMS

 –  PAWP, CO, SVR, dysrhythmias, S4,

cardiac failure, cardiogenic shock

 – Diaphoresis, pallor, referred pains

 – Diabetics and women often present abnormalsymptoms

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 10/160

Coronary Circulation

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 11/160

I AVR V1 V4

II AVL V2 V5

III AVF V3 V6

II

 V

12 Lead ECG

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 12/160

ST ELEVATIONS

 – Anterior Wall MI 

Leads V1-V4 

Reciprocal changes in leads II, III, and aVF 

 Area supplied by the LAD

 – Inferior Wall MI Leads II, III and aVF

Reciprocal changes in leads I, and aVL

 Area usually supplied by the RCA 

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 13/160

ST ELEVATIONS

 – Lateral Wall MI

I, aVL, V5 and V6

 Area supplied by the Circumflex artery

 – Posterior Wall MI

Reflected on the opposite walls

Opposite deflections

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 14/160

Coronary Arteries

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 15/160

 Anterior Wall MI

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 16/160

Inferior Wall MI

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 17/160

COMPLICATIONS

 – Dysrhythmias, heart failure, pericarditis,ventricular aneurysms, ventricular thrombus,

VSD, mitral regurgitation, papillary muscle (or

chordae tendineae) rupture, pericardial

effusions, pericarditis

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 18/160

NURSING INTERVENTIONS – O2

 – Bedrest – Serial ECG’s 

 – Serial cardiac enzymes

 – Keep pain free (NTG. MSO4)

 – MONA (Morphine, O2, Nitroglycerin, Aspirin), Heparin, beta-blockers, and ace inhibitors. May also

include thrombolytics or Gp2b3a inhibitors

 – PCI, PTCA, IABP, CABG

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 19/160

TREATMENT

 – Time Is Heart Muscle

 – Prompt ECG

 – Goals: Relieve pain, limit the size of the

infarction and to prevent complications(primarily lethal dysrhythmias)

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 20/160

TREATMENT

 – MONA (Morphine, O2, Nitroglycerin, Aspirin),

Heparin, beta-blockers, and ace inhibitors. May

also include thrombolytics or Gp2b3a

inhibitors

 – Cardiac Catheterization (with angioplasty,atherectomy and/or stent)

 – IABP, CABG, Education

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 21/160

Balloon Angioplasty

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 22/160

Vascular Stent Deployment

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 23/160

 Atherectomy

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 24/160

SPECIFIC TREATMENTS

 – Inferior Wall (IWMI)

Fluids (with RV infarct)

Inotropics

 Afterload reducing medications

 – Anterior Wall (AWMI)

Diuretics

Inotropics

 Afterload reducing medications

 Acute Myocardial Infarction

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 25/160

 Aortic Aneurysms

DEFINITION

 – A bulge or ballooning of the aorta

When the walls of the aneurysm include all three

layers of the artery, they are called true aneurysms

When the wall of the aneurysm include only the

outer layer, it is called a pseudo-aneurysm

 – May be thoracic or abdominal

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 26/160

 Aortic Aneurysms

CAUSES

 Atherosclerosis

Marfan syndrome

Hypertension

Crack cocaine usage

Smoking

Trauma

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 27/160

 Aortic Aneurysms Rupture

 An aortic aneurysm, depending on its size, mayrupture, causing life-threatening internal bleeding

The risk of an aneurysm rupturing increases as theaneurysm gets larger

The risk of rupture also depends on the location ofthe aneurysm

Each year, approximately 15,000 Americans die of aruptured aortic aneurysm.

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 28/160

 Aortic Aneurysms

CLASSIFICATIONS

 – Classified by shape, location along the aorta,and how they are formed

 – May be symmetrical in shape (fusiform) or a

localized weakness of the arterial wall (saccular)

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 29/160

 Aortic Aneurysms

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 30/160

 Aortic Aneurysms

SIGNS & SYMPTOMS

 – Often produces no symptoms

 – If an aortic aneurysm suddenly ruptures it presents

with extreme abdominal or back pain, a pulsating

mass in the abdomen, and a drastic drop in blood

pressure

 – An increase in the size of an aneurysm means an

increased in the risk of rupture

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 31/160

 Aortic Aneurysms

THORACIC SIGNS & SYMPTOMS

 – Back, shoulder or neck pain

 – Cough, due to pressure placed on the trachea

 – Hoarseness

 – Strider, dyspnea

 – Difficulty swallowing

 – Swelling in the neck or arms

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 32/160

 Aortic Dissections

DEFINITION

 – Tearing of the inner layer of the aortic wall, whichallows blood to leak into the wall itself and causes

the separation of the inner and outer layers

 – Usually associated with severe chest pain

radiating to the back

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 33/160

 Aortic Dissections

A. Dissection

beginning in the

ascending aorta

B. Whenever the

ascending aorta

is not involved

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 34/160

 Aortic Dissections

A. Dissection

beginning in the

ascending aorta

B. Whenever the

ascending aorta

is not involved

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 35/160

 Aortic Dissections

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 36/160

Aortic Dissections

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 37/160

 Aortic Aneurysms

COMPLICATIONS

Rupture

Peripheral embolization

Infection

Spontaneous occlusion of aorta

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 38/160

 Aortic Aneurysms

TREATMENT

Medical management

 – Controlled BP (within specific range)

Surgical repair

> 4.5 cm in Marfan patients or > 5 cm in non-Marfan patients will require surgical

correction or endovascular stent placement

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 39/160

Cardiomyopathy

DEFINITION

 – Diseases of the heart muscle thatcause deterioration of the function of

the myocardium

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 40/160

Cardiomyopathy

CLASSIFICATIONS – Primary / Idiopathic (intrinsic) 

Heart disease of unknown cause, although viralinfection and autoimmunity are suspected causes

 

 – Secondary (extrinsic) 

Heart disease as a result of other systemic diseases,

such as autoimmune diseases, CAD, valvular

disease, severe hypertension, or alcohol abuse 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 41/160

Cardiomyopathy

Hypertropic Cardiomyopathy

Restrictive Cardiomyopathy

Dilated Cardiomyopathy

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 42/160

Hypertropic Cardiomyopathy

Bizarre hypertrophy of the septum

 – Previously called IHSS

Idiopathic Hypertropic Subaortic Stenosis

 – Known as HOCM

Hypertropic Obstructive Cardiomyopathy

Positive inotropic drugs Should Not Be Used

 –    Contractility will  outflow tract obstruction

Nitroglycerin Should Not Be Used

 – Dilation Will Worsen The Problem

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 43/160

Harley

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 44/160

Hypertropic Cardiomyopathy

TREATMENT – Relax the ventricles

Beta Blockers

Calcium Channel Blockers

 – Slow the Heart Rate  Increase filling time

 – Use Negative Inotropes Optimize diastolic filling

 – Do Not use NTG Dilation will worsen the problem

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 45/160

Restrictive Cardiomyopathy

Rigid Ventricular Wall

 – Due to endomyocardial fibrosis

 – Obstructs ventricular filling 

Least common form

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 46/160

Restrictive Cardiomyopathy

TREATMENT

 – Positive Inotropics

 – Diuretics

 – Low Sodium Diet

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 47/160

Dilated Cardiomyopathy

Grossly dilated ventricles without hypertrophy 

 – Global left ventricular dysfunction

 – Leads to pooling of blood and embolic episodes

 – Leads to refractory heart failure

 – Leads to papillary muscle dysfunction secondary

to LV dilation

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 48/160

Dilated Cardiomyopathy

TREATMENT

 – Positive Inotropes

 –  Afterload Reducers

 –  Anticoagulants with Atrial Fib

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 49/160

Cardiomyopathies

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 50/160

Cardiomyopathy

GENERALIZED TREATMENT – Positive Inotropes 

Except with Hypertropic Cardiomyopathy

 – Vasodilators Except with Hypertropic Cardiomyopathy 

 – Reduce Preload & Afterload – Diuretics

 – Beta Blockers

 – Calcium Channel Blockers

 – IABP

 – Vasodilators (as indicated) – Fluid Restriction

 – Daily weights, prn O2, planned activities,education, and emotional support

 – Consider Heart Transplant

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 51/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 52/160

Conduction Defects

STABLE VS UNSTABLE

 – Stable Start with medications

 – Unstable

Shock (cardioversion or defibrillation)

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 53/160

Normal Sinus Rhythm

Heart Rate 60 - 100 bpm

Rhythm Regular

P Wave Before each QRS & identical

PR Interval (in seconds) 0.12 to 0.20

QRS (in seconds) < 0.12

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 54/160

 Atrial Fibrillation

AFib

 – Multifocal atrial impulses at rate 300-600/min

 – Irregular conduction to ventricles

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 55/160

 Atrial Flutter

AFL

 –  Atrial impulses at rate of 250-350/min

 – Regularly blocked impulses at the AV node

 – Saw tooth flutter waves 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 56/160

Wandering Atrial Pacemaker

WAP

 – Multiple ectopic foci in the atria 

 – Three or more p wave morphologies

 – Rate < 100 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 57/160

Supraventricular Tachycardia

SVT

 – Supraventricular rhythm at rate 150-250

 – P waves cannot be positively identified 

 Atrial Tach = supraventricular rhythm with p wave morphology

that is noticeably different from the sinus p wave

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 58/160

Ventricular Tachycardia

VT

 – Ventricular rate of 100-250/min

 – Wide QRS

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 59/160

Torsades de Pointes

Polymorphic VT

 – VT with alternating ventricular focus

 – Often associated with prolonged QT Rate < 100

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 60/160

Heart Blocks (AV Blocks)

Sinus Rhythm with First Degree AV Block

Sinus Rhythm with Second Degree AV Block, Type 2

Sinus Rhythm with Second Degree AV Block, Type 1

Third Degree AV Block

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 61/160

DEFINITION

 –  A condition in which the heart cannot pump

sufficient blood to meet the metabolic needs of

the body

 – Pulmonary (LVF) and/or systemic (RVF)

congestion is present.

Heart Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 62/160

DEFINITION

 – Pulmonary Edema

Fluid in the alveolus that impairs gas exchange byaltering the diffusion between alveolus and capillary

 Acute left ventricular failure causes cardiogenicpulmonary edema

Non-cardiogenic pulmonary edema is a synonym for Adult Respiratory Distress Syndrome (ARDS)

Heart Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 63/160

COMPENSATORY MECHANISMS – Sympaththetic nervous system stimulation

Tachycardia Vasoconstriction and increased SVR

 – Renin-angiotensin-aldosterone system

activation (RAAS)

Hypo perfusion to the kidneys (renin) Vasoconstriction (angiotensin) Sodium and water retention (kidneys) Ventricular dilation

Heart Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 64/160

FUNCTIONAL CLASSIFICATIONS

 – Class I

 – Class II

 – Class III

 – Class IV 

Heart Failure

(without noticeable limitations)

(symptoms upon activity)

(severe symptoms upon activity)

(symptoms at rest) 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 65/160

COMPLICATIONS

 – Hypotension

 – Dysrhythmias

 – Respiratory Failure

 – Progressive Deterioration

 – Acute Renal Failure

 – Fluid & Electrolyte Imbalances

Heart Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 66/160

TREATMENT

 – Improve Oxygenation

 – Decrease Myocardial Oxygen Demand

 – Decrease Preload

 – Decrease Afterload

 – Increase Contractility

 – Manage Dysrhythmias

 – Educate!

Heart Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 67/160

Vascular Disease

Aorto/Iliac Disease: Pre & Post PTA/Stent

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 68/160

Peripheral Vascular Disease

SYMPTOMS

PAIN

PAIN RELIEF

EDEMA

PULSES

INTEGUMENTCHANGES

ULCERS

SKIN TEMPERATURE

SEXUAL ISSUES

ARTERIAL

Upon walking

On resting, standing ordependent position of lower limbs

None

Decreased or absent

Hair lossSkin shinyNail thickeningPallor when elevatedRed when dependent

Ulcers located on toes, lateralareas or site of traumaGangrene possible

Cool

ImpotencySexual dysfunction

VENOUS

While standing

Elevation of extremities

Present, edematous

May be difficult to palpate

Brownish pigmentationMay be cyanotic whenextremities are dependent

Ulcers located on ankles,medial or pre-tibial areas

Normal or warm

Not present

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 69/160

Peripheral Vascular Disease

TREATMENTS

 – Medical

 Are they taking ASA, Coumadin, Ticlid, Plavix,Oral Contraceptives, Hormones? 

 – Invasive

PTA, atherectomy, stents

 – Surgical Grafts

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 70/160

Peripheral Vascular Disease

Bypass Grafts

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 71/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 72/160

TYPES OF SHOCK

 –  Hypovolemic Shock

 –  Cardiogenic Shock

 –  Distributive Shock

 –  Obstructive Shock

Shock

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 73/160

Shock

COMPENSATORY MECHANISMS 

 – Tachycardia

 Attempts to deliver more blood to the tissues – Vasoconstriction

 Attempts to maintain adequate BP in order to

adequately perfuse the body tissues

 – Increased ADH Secretion

 ADH makes the body hold onto water in an effort to

maintain volume and thus enough blood pressure to

perfuse the body tissues

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 74/160

Types of Shock

Hypovolemic Shock – Inadequate perfusion to the tissues due to insufficient

intravascular volume 

Cardiogenic Shock – Inadequate perfusion to the tissues due to heart failure

Distributive Shock – Inadequate perfusion to the tissues due to blood flow out of the

intravascular space causing insufficient intravascular volume –  Anaphylactic, Septic, and Spinal Shock

Obstructive Shock  – Inadequate perfusion to the tissues due to obstruction of blood flow

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 75/160

Hypovolemic Shock

SIGNS & SYMPTOMS Low BP Tachycardia

Orthostatic Hypotension RestlessnessConfusion Agitation (or listless)

Thirst Pallor

Cool, Clammy Skin Resp. Rate

UOP CO

PAWP CVP

SVR Lactate Levels

 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 76/160

Hypovolemic Shock

TREATMENT

 – Volume (IVF, Blood)

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 77/160

Cardiogenic Shock

SIGNS & SYMPTOMS 

Low BP  Restlessness 

Agitation (or listless) Confusion

Tachycardia Pallor

UOP CO

PAWP (low with RVF) CVP

SVR Lactate Levels

JVD Peripheral Edema

Ventricular Gallop (S3) Dyspnea

Pulmonary Crackles 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 78/160

TREATMENTBedrest O2

CO Positive Inotropes

Preload & Afterload Diuretics

Vasodilators Positioning

Myocardial Demand IABP

Cardiogenic Shock

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 79/160

 Anaphylactic Shock

SIGNS & SYMPTOMS 

Low BP Tachycardia

Restlessness Confusion

Agitation (or listless) ThirstPallor Warm Feeling

Pruritus Hives

Angioedema Bronchoconstriction

Wheezing Laryngeal Edema

Dyspnea Cool, Clammy Skin

UOP CO

PAWP CVP

SVR Lactate Levels

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 80/160

TREATMENT – Epinephrine

 – IVF

 – Vasoconstrictors

 – Support/Maintain Airway

 Anaphylactic Shock

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 81/160

Obstructive Shock

SIGNS & SYMPTOMS 

Low BP Tachycardia

Restlessness ConfusionAgitation (or listless) Pallor

Cool, Clammy Skin CO , UOP

Symptoms related to cause

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 82/160

Obstructive Shock

CAUSES

Pulmonary Embolus Tamponade

Tension Pneumothorax Aortic Aneurysm 

TREATMENT 

Treat the Cause

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 83/160

Cardiogenic Shock is the only shock with  PAWP

Early (Hyperdynamic) Shock is the only shock with  CO and  SVR

Neurogenic Shock is the only shock with  Bradycardia

 Anaphylactic Shock has the definitive characteristic of wheezing dueto bronchospasm

Parameter Hypovolemic Cardiogenic Neurogenic Anaphylactic Early Septic Late Septic

CVP/RAP            

PAWP           or Norm   

CO            

BP            

SVR            

HR         Normal  

Shock Profiles

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 84/160

  SIRS Sepsis Severe Septic MODS DeathInfection Sepsis Shock

Sepsis Syndrome 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 85/160

Sepsis –   SIRS’ response with presumed/confirmed infection 

Severe Sepsis – Sepsis associated with organ dysfunction, hypoperfusion

(lactic acidosis, oliguria, altered mental status etc.), or

hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg) 

Septic Shock – Sepsis with perfusion abnormalities and hypotension

despite adequate fluid resuscitation

Sepsis Syndrome

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 86/160

EARLY STAGE (Hyperdynamic)Normal BP Tachycardia

Confusion Agitation (or listless)

 Respiratory Rate Temperature

Normal Color Normal or

 UOPNormal PAWP  CO  SVR

LATE STAGE (Hypodynamic)Low BP Tachycardia

Orthostatic Hypotension Restlessness

Confusion Agitation (or listless)

Thirst Pallor

Cool, Clammy Skin  UOP

 CO  PAWP

 CVP  SVR

 Lactate Levels

Septic Shock

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 87/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 88/160

3. Improve Perfusion

 – Prevent organ dysfunction

 – Treat temp as needed

2. Treat The Cause  – Pan culture, antibiotics

 – Seek primary site of infection

 – Direct therapy to primary cause

1. Stabilize The Patient

 – Fluids (lots of fluids) 150ml/hr or more

 – Vasoconstrictors

Treatment for Sepsis 

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 89/160

HEMODYNAMICS

Invasive PA Catheter

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 90/160

Invasive PA Catheter

CONTRAINDICATIONS

Mechanical Tricuspid or Pulmonary Valve

Right Heart Mass (thrombus and/or tumor)

Tricuspid or Pulmonary Valve Endocarditis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 91/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 92/160

Stroke Volume

Components Stroke Volume

 – Preload: the volume of blood in the ventricles

at end diastole and the stretch placed on themuscle fibers

 – Afterload: the resistance the ventricles must

overcome to eject it’s volume of blood 

 – Contractility: the force with which the heart

muscle contracts (myocardial compliance)

PAC Insertion Sequence

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 93/160

PAC Insertion Sequence

Phl b i A i

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 94/160

Phlebostatic Axis

4th ICS Mid-chest, regardless of head elevation

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 95/160

RAP (CVP)

RVP

PAP

PAWP

SVR

0-8 mmHg

15-30/0-8 mmHg

15-30/6-12 mmHg

8 - 12 mmHg

700-1500 dynes/sec/cm2

Normal Hemodynamic Values

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 96/160

Normal Hemodynamic Values

Values normalized for body size (BSA)

CI:  2.5 – 4.5 L/min/m2

SVRI:  1970 – 2390 dynes/sec/cm-5/m2

SVI or SI:  35 – 60 mL/beat/m2

EDVI: 60 – 100 mL/m2

Mixed Venous Oxygen Saturation

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 97/160

Mixed Venous Oxygen Saturation

SvO2

End result of O2 delivery and

consumption

Measured in the pulmonary artery

An average estimate of venous saturation for

the whole body.

Does not reflect separate tissue perfusion oroxygenation

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 98/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 99/160

Measuring PA Pressures

Measure All Hemodynamic Valuesat End-Expiration

 –   “Patient Peak”  

 –   “Vent Valley”  

S t R i ti

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 100/160

Spontaneous Respirations

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 101/160

Measure all pressures at end-expiration

At top curve with Spontaneous Respiration

“patient-peak”

 

Intrathoracic pressure decreases duringspontaneous inspiration

 – Negative deflection on waveforms

Intrathoracic pressure increases during spontaneous expiration

 – Positive deflection on waveforms

Measuring PA Pressures

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 102/160

Measure all pressures at end-expiration

At bottom curve with mechanical ventilator

“Vent-

Valley” 

Intrathoracic pressure increases duringpositive pressure ventilations (inspiration)

 – Positive deflection on waveforms

Intrathoracic pressure decreases duringpositive pressure expiration

 – Negative deflection on waveforms

Measuring PA Pressures

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 103/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 104/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 105/160

a-wave

 – Atrial contraction

 – Correct location for measurement of PAWP  Average the peak & trough of the a-wave

 – Begins near the end of QRS or at the QTsegment

Delayed ECG correlation from CVP sincePA catheter is further away from left atrium

PAWP Waveform

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 106/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 107/160

PAWP Waveform

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 108/160

BREAK!

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 109/160

 ARDS

Drowning

Pneumothorax

Respiratory

Failure

Respiratory Alterations

Chronic Lung 

Disease

Pneumonia

Pulmonary Embolism

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 110/160

 ARDS

DEFINITIONS

 – Severe respiratory failure associated with pulmonary

infiltrates (similar to infant hyaline membrane disease)

 – Pulmonary edema in the absence of fluid overload or

depressed LV function (Non-cardiogenic pulmonary edema)

 – Originates from a number of insults involving damage to thealveolar-capillary membrane

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 111/160

Acute Respiratory Distress Syndrome

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 112/160

 ARDS

PATHOPHYSIOLOGY

 – Inflammatory mediators are released causing extensive

structural damage

 – Increased permeability of pulmonary microvasculature

causes leakage of proteinaceous fluid across the alveolar  –

capillary membrane

 –  Also causes damage to the surfactant-producing type II cells

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 113/160

 ARDS

CXR CHARACTERISTICS

 – Normal size heart

 – No pleural effusion

 – Ground Glass appearance

 – Often normal early in the disease but may rapidly

progress to complete whiteout

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 114/160

 ARDS

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 115/160

 ARDS

SIGNS & SYMPTOMS – Symptoms develop 24 to 48 hours of injury

Sudden progressive disorder

Pulmonary edema Severe dyspnea

Hypoxemia REFRACTORY to O2

Decreased lung compliance

Diffuse pulmonary infiltrates

 – Symptoms may be minimal compared to CXR  – Rales may be heard

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 116/160

 ARDS

Common Risk

Factors  Other Risk Factors Sepsis

Massive

Trauma

Shock

Multiple

TransfusionsPneumonia

 Aspiration

Infection 

Smoke inhalationInhaled toxins 

Burns

Near Drowning

DKA

PregnancyEclampsia

 Amniotic Fluid Embolus

Drugs 

 Acute PancreatitisDIC

Head Injury

ICP

Fat Emboli

Blood ProductsHeart/Lung Bypass 

Tumor Lysis

Pulmonary Contusion Narcotics 

RISK FACTORS

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 117/160

 ARDS

TREATMENT

 – Respiratory Support

 – PEEP, CPAP

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 118/160

Chronic Lung Disease

COPD

 – Presents with hyper-inflated lung fields

Due to chronic air trapping May be barrel chested

 – May lead to cor pulmonale (right-sided heart failure)

Due to chronic high pulmonary pressures

 – Often hypercarbic (high pCO2)

Often dependent upon hypoxic drive

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 119/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 120/160

Near Drowning

Salt Water

 – Causes body fluids to shift into lungs 

Osmosis: From low to high concentration

Results in hemoconcentration & hypovolemia

 – Results in acute pulmonary edema

Fresh Water

 – Fluids shift into body tissues

Results in hemodilution & hypervolemia

Can result in gross edema

 – Damaged alveoli fill with proteinaceous fluid

May lead to pulmonary edema

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 121/160

Pneumonia

Lung infection (bacterial, viral, or fungal) 

 – Most commonly caused by Streptococcus

 pneumoniae 

Symptoms include fever, pleuretic chest

pain, productive cough, and tachypnea

 – Often presents bronchial breath sounds over the

lung area

Treatment involves giving the right antibiotic

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 122/160

P th

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 123/160

Pneumothorax

T i P th

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 124/160

Tension Pneumothorax

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 125/160

P th

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 126/160

Pneumothorax

SIGNS & SYMPTOMS

 – Standard Pneumothorax Sharp "pleuritic" chest pain, worse on breathing

Sudden shortness of breath Dry, hacking cough (may occur due to irritation

of the diaphragm)

May cause mediastinal shift

 – Tension pneumothorax Signs of standard pneumothorax with signs of

cardiovascular collapse

Immediately life threatening

May cause mediastinal shift

P th

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 127/160

Pneumothorax

TREATMENT

Spontaneous pneumothorax

 – Depends on symptoms & size of pneumothorax

 – Provide respiratory support

 – May need chest tube or needle decompression

Some resolve without intervention

Tension pneumothorax

 – Requires immediate intervention

 – May cause cardiovascular collapse

 – May need chest tube or needle decompression

2nd intercostal space

P th

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 128/160

TREATMENT

 – Pleurodesis 

Pneumothorax

Chemical or surgical adhesion of the lung

to the chest wall

Used for multiple collapsed lungs or

persistent collapse

Fl il Ch t

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 129/160

Flail Chest

P l E b li

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 130/160

Definition 

Signs & Symptoms

Pulmonary Embolism

 –  Arterial embolus that obstructs blood flow to the lung

 – Symptoms include sudden dyspnea, cough, chest

pain, hemoptysis and sinus tachycardia

 – Blood gas shows low pO2 & low pCO2

 –  May present positive Homan’s Sign 

 – May present loud S2

P l E b li

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 131/160

Diagnostic Tests 

 – CXR

 – VQ Scan

 – Spiral CT

 – Pulmonary arteriogram/angiogram

 – Venous ultrasound of the lower extremities

 –  ABG with low pO2 & low pCO2

 – D-Dimer

Pulmonary Embolism

P l E b li

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 132/160

Treatment 

 – Requires immediate intervention

 – Provide respiratory support

 – Treat pain & comfort – Usually includes intravenous heparin 

Heparin reduces risk of secondarythrombus formation while clot is reabsorbed

 – May require embolectomy

 – May require thrombolysis

 – May need umbrella filter

 – May need long term anticoagulants

Pulmonary Embolism

R i t F il

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 133/160

Respiratory Failure

DEFINITIONS

 – Failure to maintain adequate gas exchange

 – Inadequate blood oxygenation or CO2 removal

 – PaO2 < 50 mmHg and/or PaCO2 > 50 mmHg

and/or pH < 7.35 on Room Air

Respirator Fail re

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 134/160

Respiratory Failure

TYPE I  Hypoxemia without hypercapnia 

TYPE II Hypoxemia with hypercapnia

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 135/160

Respiratory Failure

CAUSES 

 – V/Q Mismatching

 – Intrapulmonary Shunting

 –  Alveolar Hypoventilation

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 136/160

Respiratory Failure

V/Q MISMATCHING

 – COPD

 – Interstitial Lung Disease

 – Pulmonary Embolism

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 137/160

Respiratory Failure

PULMONARY SHUNTING 

 –  AV fistulas/malformations

 –  Alveolar collapse (atelectasis)

 –  Alveolar consolidation (pneumonia)

 – Excessive mucus accumulation

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 138/160

Respiratory Failure

SIGNS & SYMPTOMS 

 – Restlessness / Agitation

 – Confusion /  LOC

 – Tachycardia / Dysrhythmias

 – Tachypnea / Dyspnea

 – Cool, clammy, pale skin

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 139/160

Respiratory Failure

ARTERIAL BLOOD GASES 

 – pH 7.30 / pO2 45 / pCO2 80

 – pH 7.30 / pO2 55 / pCO2 65

 – pH 7.32 / pO2 50 / pCO2 50

 – pH 7.55 / pO2 65 / pCO2 22

Respiratory Failure

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 140/160

Respiratory Failure

TREATMENT

 – Ensure Adequate Ventilation

 –  FiO2 Ineffective with shunting

Prolonged O2 > 40% causes O2 toxicity

Must use caution with CO2 retainers

 – Chronic hypercapnia causes CO2 retainers

to use hypoxic drive

 – Too much O2 can depress respirations

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 141/160

BREAK!

CCRN REVIEW PART 1

Gastrointestinal Alterations

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 142/160

GI Bleed

Pancreatitis

Gastrointestinal Alterations

Gastrointestinal Bleeding

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 143/160

CAUSES 

 – UGI Bleeding

Includes the esophagus, stomach, duodenum 

 – Peptic Ulcer Disease (PUD), or Esophageal Varices

 – ASA, NSAID’s, Anticoagulants, Alcohol 

 – H. Pylori

 – LGI Bleeding

Includes the jejunum, ileum, colon, rectum

 – Colorectal cancer, Polyps, Hemorrhoids, IBD

Gastrointestinal Bleeding

Gastrointestinal Bleeding

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 144/160

Gastrointestinal Bleeding

Gastrointestinal Bleeding

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 145/160

Gastrointestinal Bleeding

Hematemesis  – vomiting of blood (or coffee groundmaterial) (indicates bleeding above the duodenum )

Melena  – passage of black tarry stools > 50ml (indicates

degradation of blood in the bowel)

Hematochezia – passage of red blood (rectal bleeding) 

Occult Bleeding  – bleeding that is not apparent to thepatient and results from small amounts of blood

Obscure Bleeding  – occult or obvious but source notidentified

Gastrointestinal Bleeding

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 146/160

Gastrointestinal Bleeding

Hematemesis  – always UGI source

Melana  – indicates blood has been in GI tract

for extended periods – Mostly UGI – Small bowel

 – Rt colon (if bleeding relatively slow)

Hematochezia 

 – Mostly colon

 – Massive UGI bleeding (not enough time for degradation)

Gastrointestinal Bleeding

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 147/160

TREATMENT  – Find the underlying cause

 – Fluid volume replacement

 – Endoscopy or colonoscopy

 – Medical and /or surgical therapy Somatostatin 

IV or intra-arterial vasopressin

Sclerotherpay

 Angiography with embolization Electrocoagulation

Band ligation

Balloon tamponade (Sengstaken-Blackmore tube) 

Gastrointestinal Bleeding

The Pancreas

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 148/160

The Pancreas

The Pancreas secretes digestive enzymes,

bicarbonate, water, and some electrolytes into

the duodenum via the pancreatic duct

 – Lipase, Amylase, Trypsin

The Pancreas also produces

and secretes insulin

Pancreatitis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 149/160

Pancreatitis

DEFINITION

 – An autodigestive process resulting

from premature activation ofpancreatic enzymes

Pancreatitis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 150/160

Pancreatitis

PATHOSHYSIOLOGY

• Inactive pancreatic enzymes are activated outside

of the duodenum

• The swelling pancreas causes fluids to shift into

the retro peritoneum and bowel

• Fluid shifts can cause severe hypovolemia and

hypotension

• Inflammation cause commotion around pancreas

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 151/160

Pancreatitis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 152/160

Pancreatitis

SIGNS & SYMPTOMS

 – Abdominal Pain

 – Nausea & Vomiting – Abdominal Distention

 – Jaundice

 – Malnutrition

 – Hematemesis

 – Grey Turner’s Sign 

 – Cullen’s Sign 

 – Elevated Amylase,

Lipase, LDH, AST, WBC’s

BUN, and Glucose

Pancreatitis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 153/160

Pancreatitis

COMPLICATIONS – Hypocalcemia

 – Hypotension

 – Acute Tubular Necrosis

 – DIC

 – Obstructive Jaundice

 – Erosive Gastritis

 – Paralytic Ileus

 – Pseudocyst or Abscess – Bowel Infarction

 – Internal Bleeding

 – Fat Necrosis

 – Pleural Effusion (left)

 – Pulmonary Infiltrates

 – Hypoxemia

 – Atelectasis

 – ARDS

 – Pericardial Effusion

 – Mediastinal Abscess

 – Hyperglycemia

 – Hypertriglyceridemia

 – Encephalopathy

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 154/160

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 155/160

Pancreatitis

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 156/160

Pancreatitis

FULMINATING PANCREATITIS

• Signs & Symptoms

Tachycardia & low BP (may be the only sign)

Pulmonary & cerebral insufficiency

Acute diabetic ketosis or oliguria

Hemorrhagic pancreatitis may appear

CCRN REVIEW

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 157/160

THE ENDPART 1 

CCRN REVIEW PART 1

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 158/160

THANK YOU

References

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 159/160

References

 American Heart Association. (2005). Guidelines 2005 for CardiopulmonaryResuscitation and Emergency Cardiovascular Care. Available at:www.americanheart.org.

Bridges EJ.(2006) Pulmonary artery pressure monitoring: when, how, andwhat else to use. AACN Adv Crit Care. 2006;17(3):286 –303.

Chulay, M., Burns S. M. (2006). AACN Essentials of Critical Care Nursing.McGraw-Hill Companies, Inc., Chapter 23.

Finkelmeier, B., Marolda, D. (2004) Aortic Dissection, Journal ofCardiovascular Nursing: 15(4):15 –24.

Hughes E. (2004). Understanding the care of patients with acute pancreatitis.Nurs Standard: (18) pgs 45-54.

Sole, M. L., Klein, D. G. & Moseley, M. (2008). Introduction to Critical CareNursing. 5th ed. Philadelphia, Pa: Saunders.

Thelan, L. A., Urden, L. D., Lough, M. E. (2006). Critical care: Diagnosis andTreatment for repair of abdominal aortic aneurysm. St. Louis, Mo.:Mosby/Elsevier. pg 145-188.

References Continued

8/12/2019 CCRNPart1

http://slidepdf.com/reader/full/ccrnpart1 160/160

References Continued

Urden, L., Lough, M. E. & Stacy, K. L. (2009). Thelan's Critical Care Nursing:Diagnosis and Management (6th ed). St. Louis, Mo.: Mosby/Elsevier.

Woods, S., Sivarajan Froelicher, E. S., & Motzer, S. U. (2004). Cardiac Nursing.5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins.

Wynne J, Braunwald E. (2004). The Cardiomyopathies in Braunwald's Heart

Disease: A Textbook of Cardiovascular Medicine (7th Edition). Philadelphia:W.B. Saunders, vol. 2, pps. 1659 –1696, 1751 –1803.

Zimmerman & Sole. (2001). Critical Care Nursing (3rd Edition). WB Saunders.,pgs. 41-80, 176-180, 242-266.

 Anderson, L. (July 2001). Abdominal Aortic Aneurysm, Journal ofCardiovascular Nursing:15(4):1 –14, July 2001.

Irwin, R. S.; Rippe, J. M. (January 2003). Intensive Care Medicine. LippincottWilliams & Wilkins Philadelphia: pgs 35 548